ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2233

Machine Learning Uncovers Novel mRNAs Expressed in Fibromyalgia

Lena Kolb1, Mark Rudolph1, Alan Kivitz2, Scott Rey1, Roberta Alexander1, Anja Kammesheidt3 and Geoffrey Stephens1, 1Exagen, Inc., Vista, CA, 2Department of Rheumatology, Altoona Center for Clinical Research, Duncansville, PA, 3self, Laguna Beach, CA

Meeting: ACR Convergence 2022

Keywords: Diagnostic criteria, fibromyalgia, Gene Expression, genomics, informatics

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2022

Title: Abstracts: Fibromyalgia and Other Clinical Pain Syndromes

Session Type: Abstract Session

Session Time: 4:30PM-5:30PM

Background/Purpose: Fibromyalgia is a debilitating pain condition that affects roughly 12 million people in the United States. Although preliminary diagnostic criteria have been established by the ACR, the diffuse nature of the symptomology often precludes a definitive diagnosis. Here, we have identified a potential combination of biomarkers to enable a more objective diagnostic approach for fibromyalgia patients. To that end, a multi-center study was conducted to collect blood samples from diverse groups of patients whose symptomatology is often similar to fibromyalgia and whole transcriptome sequencing was performed.

Methods: Subjects: Samples from 26 individuals with fibromyalgia, 14 with systemic lupus erythematosus (SLE), 11 with rheumatoid arthritis (RA), and 14 normal donors (NHV) were analyzed. All patients satisfied the ACR classification criteria for their respective diseases.

Sequencing: RNA was isolated from whole blood collected in PAX gene tubes from a total of 65 individuals enrolled from five sites. After determination of the quality/quantity of the isolated total RNA, reverse transcription was used to generate cDNA to which adapters were ligated. High throughput sequencing was performed at a minimum depth of 25 million per sequence using a paired read approach.

Analysis: Raw data in the form of FASTQ files was mapped to the current version of the reference human genome (GRCh38) using Rsubread. Transcript counts were normalized, fold changes were calculated, and hierarchical clustering was performed using the R package DESeq2. Multiple machine learning algorithms were trained on a subset of the normalized count data, which was further validated using a separate test/holdout data set. The light gradient boosting model was subsequently determined to generate the most reliable predictions of disease benchmarked against ACR criteria. An analysis of significant pathways associated with the identified fibromyalgia specific gene set was performed using DAVID (https://david.ncifcrf.gov).

Results: Using a combination of traditional informatics and machine learning approaches, a distinct set of transcripts were identified in RNA isolated from the whole blood of patients with fibromyalgia, other conditions, and NHV (Figure 1). Fibromyalgia patients did not show elevated expression of type 1 IFN regulated genes, and analysis of pathway relationships showed an enrichment of genes involved in neuroactive peptide signaling, cognition, neuronal migration fibromyalgia. A machine learning approach revealed that the gene signature had significant potential value in facilitating fibromyalgia diagnosis with a detection sensitivity of 78% and a specificity of 93% (AUC of 0.96).

Conclusion: Next generation sequencing of RNA isolated from whole blood samples identified several genes that were differentially regulated in fibromyalgia patients versus those with other rheumatologic conditions. Using these data in the development of diagnostic algorithms may be a promising approach in distinguishing among diseases that have overlapping symptomology with fibromyalgia. Future studies using an orthogonal technology will be used to further validate the utility of the gene signature presented herein.

Supporting image 1

Figure 1. Volcano plot illustrating RNA transcripts differentially expressed (log2-fold changes) between 14 normal health donors (NHVs; x-axis) and 26 fibromyalgia (fibro; y-axis) patients. Red colored dots indicate transcripts that were differentially expressed with p-values < 0.05, and green dots indicate those with p-adjusted values of < 0.1.


Disclosures: L. Kolb, Exagen; M. Rudolph, Exagen, Inc; A. Kivitz, Amgen, Boehringer-Ingelheim, Janssen, Gilead, GlaxoSmithKlein (GSK), Novartis, Pfizer, Sanofi, Flexion, Eli Lilly, Genentech, UCB, AbbVie, Merck, ECOR1 CAPITAL, LLC, Chemocentryx, Regenerson, Grunenthal, Bendcare, Horizon; S. Rey, Exagen Inc.; R. Alexander, Exagen Inc.; A. Kammesheidt, Exagen Inc.; G. Stephens, Exagen Inc.

To cite this abstract in AMA style:

Kolb L, Rudolph M, Kivitz A, Rey S, Alexander R, Kammesheidt A, Stephens G. Machine Learning Uncovers Novel mRNAs Expressed in Fibromyalgia [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/machine-learning-uncovers-novel-mrnas-expressed-in-fibromyalgia/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/machine-learning-uncovers-novel-mrnas-expressed-in-fibromyalgia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology